Exam 2: NU664D NU 664D Latest

Exam 2: NU664D / NU 664D (Latest

Update 2025 / 2026) Primary Care Adult Woman I | Questions & Answers | Grade A | 100% Correct - Regis

Question:

Lysteda (TXA) dose

Answer:

650mg 2 tabs BID x 5 days during menses

Question:

Lysteda when to prescribe

Answer:

when other options have been unsuccessful to tx menorrhagia in patients who are not at high risk for thrombosis

• / 4

Question:

lysteda mechanism of action

Answer:

antifibrinolytic effect by blocking lysine bindings sites on plasminogen to prevent fibrin degradation

Question:

menorrhagia: clinical manifestations

Answer:

bleeding more than 80ml/cycle, or cycle lasting longer than 7 days

Question:

menorrhagia: differential dx

Answer:

pregnancy, cervical abnormalities, uterine abnormalities, endometriosis, medications, endocrine, foreign body

• / 4

Question:

menorrhagia: diagnostic wu

Answer:

UPT, cbc, std, pap, endometrial biopsy

depending on sxs TSH

PTT, PT

Factor VIII Von Willebrand

DHEA-S

testosterone US hysteroscopy prolactin

Question:

menorrhagia: endometrial biopsy

Answer:

for all women > 45 OR AUB and other associated risk factors (unopposed estrogen exposure, failed medical management of bleeding)

• / 4

Question:

menorrhagia: tx for hemodynamically unstable

Answer:

IV conjugated equine estrogens in combinations with surgical options

uterine curettage - diagnostic and therapeutic effect

uterine tamponade

hysterectomy - last result

endometrial ablation - also r/o malignancy

Question:

menorrhagia: TX

Answer:

low dose COC - one pill BID x 5-7 days - should slow or stop bleeding within first or second day of tx

after BID regimen continue until pack is empty or refill if desired

• / 4